Pancreatitis during treatment with liraglutide

Journal of the Pancreas

Volumn 13, Issue 5, 2012, Pages 540-541

  Famularo, Giuseppe ^a   Gasbarrone, Laura ^a   Minisola, Giovanni ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Incretins; Liraglutide; Pancreatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLICLAZIDE; LIRAGLUTIDE; METFORMIN; TRIACYLGLYCEROL LIPASE;

ADVERSE OUTCOME; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; DRUG SAFETY; DRUG WITHDRAWAL; EPIGASTRIC PAIN; HUMAN; LETTER; MALE; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREATITIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ACUTE DISEASE; AGED; DIABETES MELLITUS, TYPE 2; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; PANCREATITIS;

EID: 84866391334     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30:239-245. [PMID 7249508]
2. Pinelli NR, Hurren KM. Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Pharmacother 2011; 45:850-860. [PMID 21730278]
3. Noel RA, Braun DK, Patterson RE, et al. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study. Diabetes Care 2009; 32:834-838. [PMID 19208917]
4. Parks M, Rosebraugh C. Weighing risks and benefits of liraglutide. The FDA's review of a new antidiabetic therapy. N Engl J Med 2010; 362:774-777. [PMID 20164475]
5. Knezevich E, Crnic T, Kershaw S, et al. Liraglutide-associated acute pancreatitis. Am J Health Syst Pharm 2012; 69:386-389. [PMID 22345417]
6. Lee PH, Stockton MD, Franks AS. Acute pancreatitis associated with liraglutide. Ann Pharmacother 2011; 45:e22. [PMID 21487080]
7. Koehler JA, Baggio LL, Lamont BJ, et al. Glucagon-like peptide-1- receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice. Diabetes 2009; 58:2148-2161. [PMID 19509017]
8. Nyborg NC, Mølck AM, Madsen LW, et al. The human GLP-1 analog liraglutide and the pancreas: evidence for the absence of structural pancreatic changes in three species. Diabetes 2012; 61:1243-1249. [PMID 22338093]